Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Smitty2000on Jun 08, 2017 12:58pm

108 Views

Post# 26341018

RE:RE:RE:RE:RE:RE:RE:RE:RE:down again

bottom line is that matthews does not know how to promote. with the technology that sernova has it should be trading well over the 0.40 area. need to hire someone who knows how to advance the sp. matthews is useless.

elgin1 wrote: Yes I find FDA delay frustrating and the sudden news of Viacyte using a new device for FDA trials troubling. On top of that we have no info from the company to where we are. But the science is the key and the race is on. GLTA

Bullboard Posts

Sirios Resource discovers visible gold in Quebec